With more and more people signing up for weight loss drugs, the potential side effects are starting to attract attention.

Research suggests that weight loss can sometimes reverse the cardiac remodeling that takes place after weight gain, improving heart structure and function. “Evidence shows that lifestyle ...

“We’ve signed some pretty large contracts for liraglutide,” says chief financial officer Joshua Fritzler. “We can treat it kind of the same way we treated semaglutide and tirzepatide ...

Findings showed a 13.6% reduction in body weight in the semaglutide 25 mg group compared with a 2.2% reduction in the placebo group. The Food and Drug Administration (FDA) has accepted for review ...

Tirzepatide and semaglutide are highly effective medications for obesity management. The efficacy and safety of tirzepatide as compared with semaglutide in adults with obesity but without type 2 ...

Limited effectiveness, weight regain, and high prevalence of adverse events are the three key limitations of semaglutide highlighted in a letter published in the JAMA Cardiology. The letter is ...

A major 72-week trial shows tirzepatide leads to double-digit weight loss and greater waist reduction than semaglutide, reshaping obesity treatment strategies and offering new hope for patients ...

The study participants were real-life patients prescribed either semaglutide or liraglutide (an older GLP-1 drug) for weight loss. The participants reported their level of alcohol use before ...

GLP-1 medications belong to a class of drugs that include semaglutide, liraglutide, dulaglutide, and several others. Semaglutide is the active ingredient in Wegovy and Ozempic, two popular GLP-1 ...

Individuals who take liraglutide or semaglutide for weight loss reduce their alcohol consumption by almost two-thirds in four months, new research presented at the European Congress on Obesity ...